It is proposed that the next revision of the Australian Drinking Water Guidelines will include 'healthbased targets', where the required level of potable water treatment quantitatively relates to the magnitude of source water pathogen concentrations. To quantify likely Cryptosporidium concentrations in southern Australian surface source waters, the databases for 25 metropolitan water supplies with good historical records, representing a range of catchment sizes, land use and climatic regions were mined. The distributions and uncertainty intervals for Cryptosporidium concentrations were characterized for each site. Then, treatment targets were quantified applying the framework recommended in the World Health Organization Guidelines for Drinking-Water Quality 2011. Based on total oocyst concentrations, and not factoring in genotype or physiological state information as it relates to infectivity for humans, the best estimates of the required level of treatment, expressed as log 10 reduction values, ranged among the study sites from 1.4 to 6.1 log 10 .
INTRODUCTION
In line with the World Health Organization (WHO) Guidelines for Drinking-Water Quality (GDWQ) 2011 (WHO ) and the Australian Guidelines for Water Recycling (AGWR) (NWQMS ) the next revision of the Australian drinking water guidelines will include 'health-based targets'; that is, quantitative treatment targets for pathogens based on quantitative microbial risk assessment (QMRA). Specifically it is proposed that the required level of potable water treatment will be quantitatively related to the magnitude of the pathogen concentration in each source water.
One limiting factor for surface water supply treatment is expected to be protozoan contamination, in particular the presence of the 'reference' protozoan pathogen, Cryptosporidium due to its extreme resistance to inactivation by chlorine (LeChevallier & Au ). Cryptosporidium has been identified in a range of hosts within Australian drinking water catchments (Cox et Information on Cryptosporidium concentrations in Australian surface waters is most heavily clustered around the metropolitan supply areas in south-eastern Australia where major water utilities operating in Queensland, New South the major water utilities in these states, instigated this project to determine whether the existing historical databases held within each of these water utilities could provide the basis for estimating treatment requirements for Australian water supplies more generally. Specific objectives of the study were to:
• compile historical Cryptosporidium data from each project partner for several surface water sources representing a range of catchment sizes, land use and climatic conditions;
• characterize the distributions of Cryptosporidium in each surface water source, including the associated uncertainty in that distribution;
• quantify the treatment targets by applying the microbial 'health-based target' framework recommended in the GDWQ, and as applied in the AGWR.
METHODS

Data collection and compilation
For each of the six project partners, source water supplies were identified for which Cryptosporidium monitoring data were available, and that represented a range of different catchment types regarding the level of protection, size and land use within the catchment. For these systems the following data were requested including: Cryptosporidium (including total uncorrected counts), sample volume, method recovery data (i.e., method, number spiked and number recovered), results from molecular genotyping, faecal indicators (including Escherichia coli (E. coli), enterococci and spores of Clostridium perfringens (C. perfringens)) and physico/chemical data (including turbidity, total organic carbon (TOC), dissolved organic carbon (DOC), temperature and pH). All data were compiled in a common Excel datatable to aid QA/QC, e.g., checks for replicates, standardization of measurement units, generate summary statistics and facilitation selection and extraction of priority (Cryptosporidium) data.
Statistical analyses of Cryptosporidium data
The primary objective of the statistical analyses reported here was to characterize the Cryptosporidium concentration in surface water for each of the study systems, including the magnitude and variability of concentration. Cryptosporidium monitoring data consist of discrete counts, often with many zeros, and are the product of an imperfect detection method. Statistical analysis to facilitate appropriate parameter fitting and representative uncertainty analysis needs to be appropriate for these characteristics. Statistical models were constructed to:
1. quantify Cryptosporidium concentration for each study system based on discrete count data and accounting for method recovery;
2. estimate the probability that a confirmed oocyst was human infectious (where human infectivity was defined by the molecular tests applied by the two project partners who included genotyping assays in their monitoring programme).
Quantifying Cryptosporidium concentrations
The models for characterizing the Cryptosporidium concentration were constructed based on work published by Teunis (available online at http://www.iwaponline.com/jwh/013/ 282.pdf). For each system the deviance (À2 × log-likelihood) was used with a likelihood ratio test to compare the fit of constant concentration model with the variable (gamma distribution) concentration model. If the difference in the deviance was greater than 3.84 (χ 2 , 95% level with 1 degree of freedom), then the addition of a second parameter to describe variable concentration was supported by the data.
If the deviance was less than 3.84, it was concluded that there was no evidence in the data that the Cryptosporidium was variable, and the point estimate of the Poisson parameter was adequate to define source water concentrations.
Prediction of the proportion of human infectious Cryptosporidium
Two project partners provided data related to the human infectivity of isolated oocysts. For these systems, all confirmed oocyst counts were pooled and analysed to determine whether the sample contained the target genetic sequence. Statistically, a negative result was interpreted to mean that the sample contained zero human infectious oocysts; whereas a positive result indicated that the sample contained one or more human infectious oocysts.
The probability that an oocyst was human infectious was assumed to be a binomial process, with probability of human infectivity given by p. The probability of identifying
x human infectious oocysts, given a total of n oocysts in the sample, is therefore given by:
For data consisting of m counts with paired infectivity result δ (δ ¼ 1 for positive human infectivity and δ ¼ 0 for negative result) the likelihood function for p given an infectivity observation of δ from n pooled oocysts is given by:
For each data set, the log-likelihood function was used to find the maximum likelihood estimate (MLE) for p.
Uncertainty analysis of parameter values
To explore the uncertainty associated with the predicted 
Potential predictive variables
The predicted mean Cryptosporidium concentration was plotted against several potential predictive variables: mean E. coli concentration, mean enterococci concentration, mean C. perfringens spore concentration, mean turbidity, mean TOC, mean DOC, system size classification, system catchment protection classification and presence or absence of a reservoir.
Treatment targets
For each source water, the predicted Cryptosporidium concentration was used to quantify the required level of treatment in order to achieve the annual tolerable risk target of 1 × 10 À6 disability-adjusted life year (DALY). The method applied is illustrated in Figure 1 . Using the QMRA framework, for a particular inflow pathogen concentration, the level of treatment required in order to meet the healthbased target was then quantified. The approach relies on fixed input assumptions for the following variables.
Exposure volume
The total predicted exposure to pathogens depends upon the volume of unboiled water consumed per person per day. The amount of water consumed varies between individuals. In the context of setting guideline treatment limits, a reference value of 1 L per person per day is selected (consistent with GDWQ (WHO )).
Dose-response model
There are several dose-response models published for
Cryptosporidium. The values recommended in water quality guidelines have evolved to reflect new scientific information and statistical modelling studies. suggested a further 10-fold increase in oocyst infectivity.
To investigate the sensitivity of the quantified treatment targets to the assumed oocyst infectivity, the calculations were undertaken separately using the assumed value of the AGWR (NWQMS ) and the WHO GDWQ 4th edition (WHO ).
Exposure frequency and annualized risk: consumption of unboiled tap water is assumed to occur every day of the year. The probability of one or more infections per year (Pinf annual ) is given by:
This equation is suitable for quantifying the mean annual probability of infection, or for a single point value probability of infection. When the daily probability of infection is variable, and not a constant value, it is necessary to quantify the annual probability of infection using the following bootstrapping approach:
where Random [P inf ] is a random sample from the distribution of P inf . The full distribution of the P infannual can be estimated by repeating the simulation many thousands of times in the Monte Carlo simulation.
Probability of illness given infection
Not all infected individuals will develop symptoms of illness.
The GDWQ (WHO ) and AGWR (NWQMS ) have assumed that the probability of illness, given infection, is 0.7.
This value was therefore applied in the calculations.
DALY weighting
The DALY weighting for Cryptosporidium applied in the GDWQ (WHO ) is 1.5 × 10 À3 DALY per case of illness.
The Australian DALY study (Leder et quantile of concentration was also quantified using both a point value approach (Equation (3)), and the more appropriate bootstrapped approach (Equation (4)).
RESULTS
Data collation
Raw water quality data were obtained from all six project partners across 25 study sites. The Cryptosporidium-related parameters obtained from each partner are summarized in Table 2 , and the data sets for the study systems are summarized in Table 3 . A quantification of method recovery is essential for the concentration prediction (Petterson et al.
)
. For those systems that could not provide recovery data, a conservative value of 30% was assumed. In some cases, it was not clear whether Cryptosporidium counts were IFA þve or DAPI-confirmed counts. In those cases they were assumed to be DAPI-confirmed. Two project partners reported genotyping of DAPI-confirmed oocysts;
however, the specific methods used, and the implications regarding the Cryptosporidium species and genotypes identified by these methods, are not known.
Statistical analyses
Quantifying Cryptosporidium concentration
The results of the statistical analysis including maximum likelihood model parameters for the Poisson (no variability, Equation (A3)) statistical model and the gamma distribution (Equation (A7)) statistical models for IFA þve oocysts are The reported volume was assumed to be the volume tested, as opposed to the volume sampled. In discussions with the laboratory, the most common sample volume was 10 L. In addition, a review of reported concentrations implied what the sample volume had been.
included in Table Uncertainty analysis for some systems produced unstable results. For system 1D, the uncertainty analysis was highly unstable, evidenced by very broad uncertainty intervals (Figure 2(a) ). hence the gamma distribution model was inappropriate.
For system 4Eiv, the uncertainty analysis was unstable and did not converge on a stationary distribution for ρ and λ. For project partners 2 and 3, the DAPI-confirmed oocyst counts were identical to the IFA þve. For these systems the numbers reported in Tables 5 and 6 are identical. For project partners 1, 4 and 5, the DAPI-confirmed concentrations were 0-0.08 log 10 ; 0.12-0.95 log 10 and 0.13-0.29 log 10 lower than the IFA þve concentrations, respectively. 
Quantifying proportion of human infectious Cryptosporidium
The maximum likelihood estimators of the parameter p (probability of an oocyst being human infectious) for each of the systems with genotyping data are summarized in Table 5 . Estimated probability of human infectivity ranged from less than 2 to 57%. The probability of finding a human infectious oocyst was approximately an order of magnitude higher for systems managed by project partner 5 in comparison to project partner 4. It is essential to note that the definition of 'human infectious' is reliant upon the method used for identification. The methods used by project partners 4 and 5 are not known, and are most likely different.
Potential predictive variables
The concentration of microbial indicators E. coli, enterococci and C. perfringens are plotted against the predicted Cryptosporidium (IFA þve) concentration in (3)) and a bootstrapping approach (Equation (4)).
When the point estimate of the upper 95th percentile was used, the quantified risk was up to 1 log 10 higher than the mean risk. This, however, is an overestimation of the reality since the upper 95th percentile of concentration does not occur every day of the year. The bootstrapping approach accounts for the daily variability in concentration, and the difference from the mean is much lower (up to 0.3 log 10 for the most variable system (4Eiv), and ≈0.1 log 10 for other systems). The arithmetic mean was therefore considered suitably conservative and applied for the remainder of the treatment target calculations.
The treatment targets for the study systems based on IFA þve oocyst concentration and DAPI-confirmed oocysts concentration are reported in Table 7 and illustrated in Figure 6 .
The best estimates for the required level of treatment to achieve the health-based target for the study systems varied between 1.4 and 6.1 log 10 relying on IFA þve counts and 1.4 and 5.8 log 10 relying on DAPI-confirmed counts.
In general, the lowest levels of treatment were required for intermediate-to-large protected systems with storage reservoirs (e.g., 3B, 3A and 2D), and the highest levels of treatment were required for small unprotected systems drawing directly from a small weir within the river or stream (e.g., 5Ai, 5Aii and 5C).
Some important exceptions were noted, for example, system 4A (a large protected system with storage reservoir and very low mean E. coli concentration) was classified as requiring a relatively high level of treatment at 3.9 log 10 .
This value would be reduced to 2.9 log 10 if only DAPI-confirmed oocysts were counted. In this protected system 16 oocysts were detected from 620 L of analysed sample, of which two oocysts were DAPI-confirmed. Neither of these oocysts were positive by the genotype testing. Similarly, system 4B (a large protected system with low mean E. coli concentration) was classified as requiring 4.5 log 10 treatment, which would be reduced to 4.2 log 10 based on DAPI-confirmed oocysts. While this system is protected, 51 IFA oocysts and 31 DAPI-confirmed oocysts were detected from a total of 680 L sampled, indicating that the total Cryptosporidium load could not be assumed to be insignificant. Based on the genotyping test, 4.8% of these oocysts would be expected to be human infectious. If only these 'human infectious' oocysts were counted, the treatment target would be reduced to 2.4 log 10. Furthermore, some systems that are known to be impacted were classified as requiring lower levels of treatment. For example, system 1B (large unprotected system drawn directly from the river, with a high E. coli concentration) would require only 3.3 log 10 as the limited data set found only two oocysts (IFA þve and DAPI-confirmed) in their total volume sampled of 314 L.
DISCUSSION
In this study, existing monitoring data for Cryptosporidium from six project partners were compiled and used to characterize the Cryptosporidium concentration in 25 surface water sources in Australia drawing from catchments of different sizes, land use characteristics and climatic regions.
These concentrations were then used within the QMRA framework recommended by WHO () for drinking water treatment, and which have already been applied to develop health-based targets for recycled water treatment in Australia via the AGWR (NWQMS ).
Relying on historical monitoring data gathered not for this study, but for a wide range of purposes, over many years, from a range of laboratories and using a variety of methods, presented very significant challenges when attempting to meet the purposes of the present study. First, there was no uniformity between utilities with respect to enumeration methodology and data reporting protocols.
The use of quantitative recovery controls, reporting of IFA þve and/or DAPIor DIC-confirmed oocysts, determination of sample volume (total volume and volume filtered), and the meaning of infectivity assays, varied both between and within utilities and was not standardized.
The data supplied did not routinely come with explanations of methodology and how measurements should be interpreted. Interpretation of the data provided for the study, which was fundamental to the appropriate quantification of the Cryptosporidium concentration in surface water and hence any quantified treatment target, required ongoing discussion between the project team, project partners and associated laboratories, with many questions still do a cost-benefit analysis on the relative price of determining viability and infectivity versus providing an additional 1-3 log 10 worth of treatment.
Predicting the concentration of Cryptosporidium in the water body from the oocyst count data required more complex statistical models than are usually applied to water quality data in order to provide the most defensible possible predictions of treatment requirements, given the above limitations. The models used in this study have been widely applied for the purpose of quantifying Cryptosporidium con- Together, these two factors influence the treatment targets by 0.8 log 10 in comparison to previously applied defaults in the national water recycling guidelines (AGWR) and the WHO GDWQ 3rd edition. Hence, when applying the QMRA approach for defining national treatment targets, the sensitivity of the quantified targets to the default model inputs may not be insignificant, and the scientific data most relevant to the local context selected.
While the general pattern of the treatment requirements for each system met with expectations (e.g., higher treatment required for small impacted systems, less for large protected catchments), the identified anomalies represent a concern. Misclassification leading to a significant underestimation of treatment requirements is critical to avoid but, conversely, overestimation will lead to unnecessary treatment. Based on our analysis of historical data, relying on Cryptosporidium monitoring data as the sole means for classifying systems and defining categories is inadequate. Any classification system must also take into consideration catchment characteristics and land use, and the magnitude of faecal contamination. Pending research questions related to the relative persistence of oocysts in the environment, and the prevalence and identification of species and genotypes of Cryptosporidium of known infectivity to humans, limit the meaningfulness of quantitatively including these factors in the quantification of treatment targets.
CONCLUSIONS
In this study, the statistical analysis and interpretation of Cryptosporidium data for the setting of health-based treatment targets has been undertaken based on historical monitoring data. The following recommendations ensue from the work undertaken:
• Rather than relying on historical monitoring data, a data collection programme specifically tailored for the characterization of pathogen concentrations for the purpose of setting health-based treatment requirements needs to be defined. This programme needs to consider: the number of samples, the selection of sampling conditions, the analytical methods used, and the protocols and data reporting.
• It is recommended that international reporting guidelines for pathogen enumeration data be developed to promote transparency between utilities and laboratories, and to facilitate any future data comparisons between water utilities.
• Given the limitations of monitoring data sets for capturing the full range of variability in Cryptosporidium loading and the importance of avoiding misclassification, treatment classifications should not be defined based on Cryptosporidium enumeration data alone, but also need to take into consideration catchment knowledge, sanitary surveys and E. coli monitoring results.
• Based on the data sets analysed in this study, the arithmetic mean is a suitable statistic for defining the Cryptosporidium concentration to be used for quantifying treatment targets for drinking water exposure.
• Selection of appropriate default assumptions for the QMRA model needs to be further investigated and understood in the light of their influence upon the quantified treatment targets, and their appropriateness to the local context.
• Reasonable methods for accounting for rainfall loading events in the quantification of treatment targets are still unexplored, and need to be addressed, particularly for small flashy catchments, and water supplies protected by large storage reservoirs.
